Tenderwize
Back to tender search

Open-House Discount Agreement for Abaloparatid

Techniker Krankenkasse·Hamburg, Germany·Deadline Feb 28, 2028 · 559 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2026-01 - Abaloparatid

30/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

30 / 100

Complexity

25 / 100

Risk factors

No estimated contract value provided. The financial opportunity cannot be assessed.

Submission must be via email with qualified electronic signature or postal mail with scan. Not using standard e-procure...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Feb 2028
  • Supply of pharmaceutical products containing Abaloparatid to German statutory health insurance funds.
  • Conclusion of discount agreements under § 130c SGB V with uniform conditions.
Show full summary

Open-house procedure for discount agreements (Rabattverträge) for the active substance Abaloparatid under § 130c SGB V. The contracting authority is Techniker Krankenkasse (TK) together with HEK and hkk. This is not a standard public procurement but an open-house model where any eligible pharmaceutical entrepreneur can join during the contract term. The contract runs from 01.03.2026 to 29.02.2028 (max 24 months). No estimated value is provided. Participation is limited to pharmaceutical entrepreneurs with a valid marketing authorization for Abaloparatid. Submission is via email or post, not through the e-procurement portal.

Risks

No estimated contract value provided. The financial opportunity cannot be assessed.

Submission must be via email with qualified electronic signature or postal mail with scan. Not using standard e-procure...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical entrepreneur as defined in § 4 Abs. 18 AMG.
  • Must have a valid marketing authorization for the medicinal product containing Abaloparatid.
  • Must be established in Germany, EU, or EEA.

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria – open-house model, all eligible participants are accepted.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open-House Discount Agreement for Abaloparatid

Conclusion of discount agreements for the active substance Abaloparatid under § 130c SGB V. Open-house procedure with no exclusivity. Any pharmaceutical entrepreneur meeting eligibility criteria may join at any time during the contract term.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Feb 2026 - Feb 2028

Category

Pharmaceutical products

Award Criteria

No award criteria – open-house model, all eligible participants are accepted.

Deadline

Deadline Feb 28, 2028

Procurement Details

Publication date
27 Jan 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
62082-2026

Documents (1)

Similar tenders